Concepedia

Marek Spaczyński

MS

Statistics

Publications

46

Citations

1.9K

H-Index

24

Active since

1997

Affiliations

Poznan University of Medical Sciences(Current)

Charité - Universitätsmedizin Berlin

Wroclaw Medical University

Centrum Onkologii

University School of Physical Education in Kraków

Marek Spaczyński is an author at Poznan University of Medical Sciences specializing in oncology, medicine, and ovarian cancer.

Publications per year

1997–2018

46

Publications

46

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer

Marta Szajnik, Mirosław J. Szczepański, Malgorzata Czystowska et al. · Oncogene · 2009 · 227 citations · Full text

Life Sciences, Immunology, Oncology +14

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years

Tino F. Schwarz, Marek Spaczyński, Achim Schneider et al. · Vaccine · 2008 · 152 citations

Medicine, Immunology, Oncology +12

ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome

Paweł Surowiak, Verena Materna, Irina Kaplenko et al. · Clinical Cancer Research · 2006 · 104 citations

Medicine, Gynecology, Oncology +17

Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients

Paweł Surowiak, Verena Materna, Irina Kaplenko et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2005 · 96 citations

Medicine, Cancer Biology, Oncology +17

Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer

Martin Gore, W ten Bokkel Huinink, James Carmichael et al. · Journal of Clinical Oncology · 2001 · 93 citations

Medicine, Oncology, Pharmacology +17

1–5 of 46